The rise of weight-loss drugs like Ozempic has sparked a medical and economic revolution. For many, these medications have been life-changing, offering unprecedented control over appetite and weight. But as demand has surged, so too have the costs and supply shortages, leaving patients like Phil searching for alternatives. This has opened the door to a booming market of copycat drugs and compounded versions, raising questions about legality, safety, and the future of pharmaceutical access in America.